4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-25-004128
Chief Operating Officer gave up 613 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Devroe Eric · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-14 | Shares withheld for taxes : show line 1 in the form | −613 | $2.24 | $1,373 | 65,308 | D |
Loading xslF345X05/form4.xml…